Loading VEEV detail
Loading ticker data...
Loading VEEV detail
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009.
Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Chart data unavailable
In the closing of the recent trading day, Veeva Systems (VEEV) stood at $151.43, denoting a -3.6% move from the preceding trading day.
Veeva Systems Inc. is upgraded to a Buy as valuation resets after a 30% YTD decline, despite continued strong fundamentals. VEEV's specialized, regulated software for life sciences makes it resilient to AI disruption and entrenched with major industry players. Revenue and billings growth remain in the mid-teens, with FY27 guidance targeting low-teens growth and mid-40s margins—approaching the Rule of 60.
Pre-Market Stock Futures: The futures are trading mixed as we approach the end of one of the most volatile and wild trading weeks in recent memory. After starting the day lower on Thursday as mixed reports on the success of the ships passing through the Strait of Hormuz rolled in, stocks gained momentum as the... Here Are Friday's Top Wall Street Analyst Research Calls: Autodesk, Delek US Holdings, Insmed, Nike, Nutanix, ServiceNow, Shake Shack, Southern Copper, Veeva Systems, and More
VEEV expands RIM capabilities via RegASK AI partnership, adding real-time regulatory intelligence to boost compliance efficiency and decision-making.
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
NEW YORK & SINGAPORE--(BUSINESS WIRE)--RegASK, the Agentic AI platform redefining regulatory intelligence and workflow orchestration, today announced its partnership with Veeva Systems, a leading provider of industry cloud solutions for the global life sciences industry. RegASK is joining the Veeva AI Partner Program to integrate with Veeva's Regulatory Information Management (RIM) system, enabling life sciences organizations to connect near-real-time regulatory signals with established complia.
Veeva Systems (VEEV) closed at $172.52 in the latest trading session, marking a -1.21% move from the prior day.
VEEV's strong Q4, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.
Veeva Systems is reiterated as a Buy, with the growth thesis now supported by traction across R&D, Quality, Commercial, and AI-driven solutions. R&D and Quality modules are gaining adoption among the top 20 biopharmas, broadening VEEV's customer base and cross-sell opportunities beyond core products. Vault CRM is driving stronger Commercial Solutions growth and acting as a catalyst for cross-selling adjacent products, increasing wallet share and customer stickiness.
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Veeva Systems is a top player in its corner of the cloud market and benefits from a competitive edge. The company's large addressable market and new AI-powered tools could help improve its results.
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks are HRB, SPWH, SERA, VEEV and WKHS.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Barlow Wealth Partners LLC cut its holdings in Veeva Systems Inc. (NYSE: VEEV) by 31.3% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 37,089 shares of the technology company's stock after selling 16,908 shares during the quarter. Barlow Wealth Partners LLC's holdings in Veeva
